🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-center, open Phase I study, to observe the effective...
Status
Unknown
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2022-01-01
Trial ID
NCT05201118
This is a multi-center, phase 2, single arm, open-label study of oral selin...
Status
Terminated
Location
University of Arizona Cancer Center
Start Date
2014-11-14
Trial ID
NCT02138786
Treatments Being Tested
The main purpose of this study is to determine the recommended doses of sel...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2014-09-23
Trial ID
NCT02186834
Treatments Being Tested
An unrandomized phase 2 study of selinexor in combination with lenalidomide...
Status
Active Not Recruiting
Location
Aalborg University Hospital
Start Date
2021-08-18
Trial ID
NCT04717700
Treatments Being Tested
The main purpose of this study is to evaluate the activity, safety and redu...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-04-30
Trial ID
NCT04355676
Treatments Being Tested
Double-blind study will compare the efficacy and assess safety of selinexor...
Status
Withdrawn
Location
James R. Berenson MD, Inc
Start Date
2015-12
Trial ID
NCT02628704
Treatments Being Tested
The main purpose of this study is to establish a safe and tolerable dose co...
Status
Withdrawn
Location
Columbia University Medical Center
Start Date
2020-11
Trial ID
NCT03880123
This is a global, multicenter, 2-part study to evaluate the efficacy and sa...
Status
Active Not Recruiting
Location
UAB Division of Hematology/Oncology
Start Date
2021-03-11
Trial ID
NCT04562389
Treatments Being Tested
This is a single-arm, open-label, multicenter, exploratory study initiated ...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2022-10-12
Trial ID
NCT05478993
Treatments Being Tested
This is a single-arm, multi-center, open-label phase 2 study of the SINE™ c...
Status
Terminated
Location
Concord Repatriation General Hospital (CRGH)
Start Date
2015-02
Trial ID
NCT02314247
Treatments Being Tested